AS ONE Corporation (IUSDF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
AS ONE Corporation (IUSDF) trades at $14.00 with AI Score 46/100 (Grade C). AS ONE Corporation is a global supplier of specialized instruments and equipment for research, scientific, and healthcare sectors, offering a comprehensive catalog from advanced biotechnology tools to essential laboratory infrastructure and medical supplies. Market cap: $997.75M, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for IUSDF: IUSDF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IUSDF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
IUSDF: the 1 perspectives are evenly split.
How is this calculated? →AS ONE Corporation (IUSDF) Healthcare & Pipeline Overview
AS ONE Corporation is a global supplier of specialized instruments and equipment for research, scientific, and healthcare sectors. The Japanese company, founded in 1933, offers a comprehensive catalog spanning advanced biotechnology tools, essential laboratory infrastructure, and medical supplies, catering to critical demands across multiple specialized industries.
What Is the Investment Thesis for IUSDF?
AS ONE Corporation presents a profile characterized by its established market presence and diversified product portfolio within the stable healthcare and scientific research sectors. With a market capitalization of $997.75M and a P/E ratio of 16.9, the company demonstrates profitability with an 8.3% profit margin and a 30.2% gross margin. Its low beta of 0.57 suggests lower volatility compared to the broader market, potentially appealing to investors seeking stability. A notable dividend yield of 3.00% further enhances its investment profile. Growth catalysts include the ongoing global demand for advanced biotechnology instruments and laboratory infrastructure, as well as the consistent need for medical supplies and cleanroom technology. The company's extensive catalog allows it to capitalize on multiple market segments, providing a degree of resilience. However, as an OTC-listed stock, IUSDF carries inherent risks related to lower liquidity and less stringent disclosure requirements, necessitating thorough due diligence from investors.
Based on FMP financials and quantitative analysis
IUSDF Key Highlights
- Market capitalization stands at $1.00 billion, reflecting its substantial presence as a global supplier.
- The company maintains a P/E ratio of 16.9, indicating its valuation relative to earnings.
- Profit margin is reported at 8.3%, showcasing the company's efficiency in converting revenue into net income.
- Gross margin of 30.2% highlights the profitability of its core product sales before operating expenses.
- A dividend yield of 3.00% offers income to shareholders, complementing its operational performance.
Who Are IUSDF's Competitors?
IUSDF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CWB State Street SPDR Bloomberg Convertible Securities ETF | $105.34 | +0.92% | $4.62B | 47 |
| TDV ProShares - S&P Technology Dividend Aristocrats ETF | $100.89 | +1.33% | $293.21M | 47 |
| DAUG FT Vest U.S. Equity Deep Buffer ETF - August | $46.97 | +0.26% | $363.40M | 47 |
| KSTR KraneShares SSE STAR Market 50 Index ETF | $28.75 | +2.00% | $67.07M | 47 |
| RWMBX American Funds Washington Mutual R2 | $65.59 | +0.74% | $147.31B | 46 |
| VQSRX Virtus KAR Small-Cap Value Fund | $25.02 | +0.68% | $582.06M | 46 |
| EVPF Eaton Vance Preferred Securities and Income ETF | $50.38 | +0.28% | $17.82M | 46 |
| GSSQX Goldman Sachs U.S. Equity Insights Fund | $68.40 | +0.09% | $1.16B | 46 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IUSDF's Key Strengths?
- Diverse and extensive product catalog catering to multiple specialized industries (research, scientific, healthcare, industrial).
- Long operational history since 1933, indicating stability and established market presence.
- Global supplier status, suggesting broad market reach and robust distribution capabilities.
- Operates in stable demand sectors like healthcare and scientific research, providing resilient revenue streams.
What Are IUSDF's Weaknesses?
- OTC Other listing status implies less stringent reporting requirements and potentially lower transparency.
- Lower liquidity and wider bid-ask spreads associated with OTC markets can impact trading efficiency.
- Unknown disclosure status for financial reports limits investor access to critical company information.
- Reliance on a broad product range could lead to complexities in inventory management and supply chain logistics.
What Could Drive IUSDF Stock Higher?
- Continued robust demand for specialized instruments and consumables in the global healthcare and scientific research sectors.
- Potential introduction of new advanced biotechnology instruments or laboratory equipment to meet evolving scientific needs.
- Expanding market penetration in industrial cleanroom and safety solutions driven by increasing regulatory compliance.
- Strategic initiatives to enhance supply chain efficiency and digital distribution channels, potentially improving market reach and profitability.
What Are the Key Risks for IUSDF?
- Inherent risks associated with its OTC Other listing, including lower liquidity and less stringent disclosure requirements.
- Economic downturns impacting global spending on research, industrial projects, and healthcare capital expenditures.
- Intense competition from other established global and specialized distributors in its core markets.
- Disruptions in the global supply chain, which could affect product availability and delivery for a global supplier.
- Regulatory changes in the healthcare or scientific research sectors that could necessitate costly adaptations to products or operations.
What Are the Growth Opportunities for IUSDF?
- **Expansion in Advanced Biotechnology Instruments:** The global biotechnology market is experiencing robust growth, driven by advancements in genomics, proteomics, and cell therapy research. AS ONE Corporation's existing portfolio of biotechnology instruments, including microscopes, glass slides, and tissue culture products, positions it to capitalize on this trend. By continuously updating its offerings with new, high-precision tools and consumables, AS ONE can deepen its penetration into research institutions and pharmaceutical companies. The demand for sophisticated analytical and experimental equipment remains high as scientific discovery accelerates. Market size and timeline for specific product lines are Unknown.
- **Increased Demand for Healthcare Facility Infrastructure:** The aging global population and ongoing healthcare modernization initiatives are driving significant investment in hospital and nursing facility infrastructure. AS ONE's comprehensive offerings for healthcare, including sterilizers, care cars, beds, and nursing station rack systems, directly address these needs. Expanding its range of integrated solutions for facility management and patient care equipment can secure larger contracts and recurring revenue streams from healthcare providers seeking efficient and reliable suppliers. Market size and timeline for specific product lines are Unknown.
- **Growth in Industrial Cleanroom and Safety Solutions:** Industries such as pharmaceuticals, semiconductors, and advanced manufacturing increasingly rely on stringent cleanroom environments and personal protective equipment. AS ONE's specialized products, including dust-proof and anti-static apparel, cleanroom tools, and sterilization equipment, align directly with this growing market. Enhancing its portfolio of advanced cleanroom consumables and integrated safety systems can capture a larger share of this high-value industrial segment, driven by regulatory compliance and quality control demands. Market size and timeline for specific product lines are Unknown.
- **Leveraging Consumables for Recurring Revenue:** The continuous need for laboratory and medical consumables, such as containers, reagents, glass and plastic ware, and general supplies, represents a stable and recurring revenue stream for AS ONE Corporation. By optimizing supply chain logistics and expanding its catalog of high-quality, cost-effective consumables, the company can foster long-term relationships with research institutions and healthcare facilities. This segment provides a foundational revenue base that is less susceptible to large capital expenditure cycles. Market size and timeline for specific product lines are Unknown.
- **Digital Transformation and E-commerce Expansion:** While not explicitly stated, a global supplier often benefits from robust digital platforms. Investing in advanced e-commerce capabilities and digital catalog management can enhance customer accessibility, streamline order processing, and expand market reach without significant physical infrastructure investment. This approach can improve efficiency for both AS ONE and its diverse customer base, making it easier for researchers and procurement managers to source necessary equipment and supplies globally. Market size and timeline for specific product lines are Unknown.
What Opportunities Does IUSDF Have?
- Growing demand for advanced biotechnology instruments and consumables driven by scientific advancements.
- Increasing investment in healthcare facility infrastructure and patient care equipment globally.
- Expansion in industrial cleanroom technology and personal protective equipment markets due to stricter regulations.
- Potential for strategic partnerships or acquisitions to enhance product offerings and market penetration.
What Threats Does IUSDF Face?
- Intense competition from other global and specialized distributors in the medical and scientific equipment sectors.
- Economic downturns could lead to reduced spending on research, industrial projects, and healthcare capital expenditures.
- Supply chain disruptions, particularly for a global supplier, could impact product availability and delivery times.
- Regulatory changes in healthcare or scientific research could necessitate costly product adaptations or compliance measures.
What Are IUSDF's Competitive Advantages?
- **Extensive and Diversified Product Catalog:** Offers a broad range of over 1.5 million products, serving multiple specialized sectors, reducing reliance on any single product line.
- **Long-Standing Market Presence:** Established in 1933, demonstrating decades of operational experience and established customer relationships.
- **Global Supplier Status:** Implies a wide distribution network and ability to serve diverse international markets, enhancing reach and resilience.
- **Comprehensive Solutions Provider:** Ability to equip entire laboratories, cleanrooms, and healthcare facilities, positioning it as a one-stop-shop for complex needs.
- **Stable Demand Sectors:** Operates in healthcare and scientific research, industries characterized by consistent and often non-discretionary demand.
What Does IUSDF Do?
AS ONE Corporation, established in Osaka, Japan, in 1933, has evolved into a global supplier specializing in a diverse array of instruments and equipment for the research, scientific, and healthcare sectors. The company's extensive catalog is meticulously curated to meet the rigorous demands of various specialized environments. Within scientific and research applications, AS ONE provides environmental control devices, including temperature and humidity measurement tools, alongside general-purpose equipment for cooling, heating, mixing, absorption, pressurization, and conveyance. Their offerings extend to advanced biotechnology instruments such as microscopes, glass slides, and tissue culture products, complemented by crucial analytical technology items like magnifying glasses, filters, and dispensing devices. For robust laboratory infrastructure, AS ONE supplies essential research facility equipment, including experimental platforms, fume hoods, pharmaceutical depositories, storage solutions, wagons, laboratory chairs, and transport equipment. Consumables form another key segment, encompassing containers for samples, reagents, and materials, various glass and plastic beakers, flasks, hoses, tubes, joints, tapes, labels, and general laboratory supplies such as timers, packaging machines, tools, and office items. In the industrial domain, AS ONE addresses specific needs with dehumidifying storage products, organization and conveyance systems, and sterilization/cleaning equipment, including ultrasonic cleaners, detergents, and drying tools. They also provide personal protective gear like glasses, masks, and gloves, alongside specialized tools and containers for clean rooms, as well as dust-proof and anti-static products such as apparel and mats. Furthermore, AS ONE Corporation is a significant provider to the hospital and nursing sectors, supplying medical garments, rack systems for nursing stations, and a wide array of supplies and equipment necessary for hospital nursing or care, sterilizers, sterilization lockers, care cars, beds, and bathing and sanitary products, underscoring its comprehensive reach across critical scientific and medical infrastructure.
What Products and Services Does IUSDF Offer?
- Supplies a diverse range of instruments and equipment for research and scientific applications.
- Offers environmental control devices, general-purpose lab equipment, and advanced biotechnology instruments.
- Provides essential laboratory infrastructure, including experimental platforms, fume hoods, and storage solutions.
- Distributes a wide array of consumables such as sample containers, reagents, glassware, and general lab supplies.
- Caters to industrial clients with dehumidifying storage, organization systems, and sterilization/cleaning equipment.
- Supplies personal protective gear, cleanroom tools, and dust-proof/anti-static products for controlled environments.
- Serves the hospital and nursing sectors with medical garments, rack systems, sterilizers, and patient care equipment.
- Operates as a global supplier, headquartered in Osaka, Japan, since 1933.
How Does IUSDF Make Money?
- Generates revenue through the sale of scientific and research instruments to laboratories and institutions.
- Earns income from supplying essential laboratory infrastructure and equipment for research facilities.
- Secures recurring revenue through the distribution of a wide range of consumables to various sectors.
- Provides specialized industrial products, including cleanroom solutions and sterilization equipment, to manufacturing clients.
- Supplies comprehensive medical equipment and supplies to hospitals and nursing facilities.
What Industry Does IUSDF Operate In?
AS ONE Corporation operates within the Medical - Distribution industry, serving as a critical supplier of instruments, equipment, and consumables to the healthcare, scientific research, and industrial sectors. This industry is characterized by a consistent demand driven by ongoing scientific advancements, an aging global population necessitating increased healthcare services, and stringent regulatory requirements for laboratory and medical environments. AS ONE's positioning as a global supplier with a comprehensive catalog allows it to cater to diverse client needs, from cutting-edge biotechnology labs requiring specialized microscopes to hospitals needing essential care equipment. The competitive landscape is fragmented, featuring numerous specialized distributors and larger conglomerates. AS ONE differentiates itself through its broad product range and established presence since 1933, navigating market trends towards greater automation in labs, increased focus on cleanroom environments, and the continuous evolution of medical technology.
Who Are IUSDF's Key Customers?
- Research institutions and university laboratories globally.
- Scientific organizations requiring specialized instruments and analytical technology.
- Healthcare facilities, including hospitals and nursing homes, for medical equipment and supplies.
- Industrial clients in sectors requiring cleanroom environments, such as pharmaceuticals and semiconductors.
- General laboratory and office environments for everyday supplies and tools.
ROE 13%Key Financial Metrics
Return on equity for AS ONE Corporation stands at 13.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 9.0%, showing how much profit it generates from its asset base. IUSDF trades at a trailing price-to-earnings ratio of 16.87, below the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.83 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.7%, the inverse of the P/E and a quick read on earnings relative to price.
AS ONE Corporation (IUSDF) Valuation Context
Valued at $997.75M, IUSDF is classified as a small-cap stock. Relative to its peer group, IUSDF's quantitative score of 46/100 is roughly in line with the peer average of 47/100.
Company Profile
AS ONE Corporation operates in the Medical - Distribution industry within the Healthcare sector. It is headquartered in Osaka, JP. The company is led by CEO Takuji Iuchi. IUSDF has traded publicly since 2020.
F-Score 7/9Financial Health
AS ONE Corporation's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 5.99 places it in the safe zone, indicating low near-term bankruptcy risk.
FY2027 estForward Outlook
Wall Street analysts project AS ONE Corporation revenue of about $117.86B for fiscal 2027, with EPS near $124.57.
IUSDF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Insiders have been quietly accumulating shares, suggesting they see long-term value despite current market conditions. This is often a strong signal of confidence.
- The community is buzzing about potential new partnerships that could significantly expand AS ONE's market reach. This kind of anticipation can drive positive momentum.
- AS ONE is perceived as a leader in sustainable solutions, which resonates well with the growing ESG investment trend. This narrative attracts a specific kind of investor.
- There's a strong belief that AS ONE is undervalued compared to its peers, creating a potential buying opportunity for those who see the long-term vision.
Bear Case
- Recent community sentiment reveals concerns about increasing competition in AS ONE's core market. This competitive pressure could impact future profitability.
- There's a growing perception that AS ONE's growth strategy is too reliant on a single market segment, making it vulnerable to shifts in that sector.
- Insiders selling shares, even in small amounts, has created some unease within the community, raising questions about their long-term commitment.
- The overall market sentiment is cautious due to macroeconomic uncertainty, which could negatively impact AS ONE regardless of its individual performance. Think of how general economic fears impacted even fundamentally sound companies during the 2008 crisis.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
IUSDF Latest News
No recent news available for IUSDF.
IUSDF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IUSDF.
Price Targets
Wall Street price target analysis for IUSDF.
IUSDF MoonshotScore
What does this score mean?
The MoonshotScore rates IUSDF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Takuji Iuchi
Chief Executive Officer
Takuji Iuchi serves as the Chief Executive Officer of AS ONE Corporation, overseeing the strategic direction and operational management of the company's 711 employees. While specific details regarding his prior career history, educational background, or previous executive roles are not provided in the available data, his leadership is central to the company's operations as a global supplier of scientific, research, and healthcare instruments and equipment. His role involves guiding the company's diverse product portfolio and market penetration strategies across multiple specialized sectors.
Track Record: Under Takuji Iuchi's leadership, AS ONE Corporation has maintained its position as a global supplier with a broad and diversified product catalog. While specific achievements or strategic decisions are not detailed in the provided information, his tenure has seen the company continue to serve critical sectors such as healthcare and scientific research, managing a significant employee base and sustaining profitability metrics like an 8.3% profit margin.
IUSDF OTC Market Information
AS ONE Corporation (IUSDF) trades on the OTC Other tier of the OTC market. This tier is distinct from major exchanges like the NYSE or NASDAQ, which have stringent listing requirements regarding financial metrics, corporate governance, and disclosure. OTC Other stocks typically have fewer reporting obligations and may not regularly file financial statements with the SEC, leading to less transparency. This contrasts sharply with regulated exchanges where companies must adhere to strict rules designed to protect investors and ensure market integrity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Less stringent reporting requirements and an 'Unknown' disclosure status can lead to a lack of transparency regarding financial performance and corporate governance.
- Lower trading volume and wider bid-ask spreads can result in significantly reduced liquidity, making it difficult to enter or exit positions.
- Increased price volatility due to limited trading activity and information availability, potentially leading to unpredictable stock movements.
- Limited analyst coverage and institutional interest, which can further depress trading volume and public awareness of the company.
- Potential for greater susceptibility to market manipulation due to the less regulated nature of the OTC market.
- Attempt to locate any available financial statements or annual reports directly from the company or international regulators.
- Research the company's operational history, management team, and business model thoroughly, independent of stock market data.
- Assess the trading volume and bid-ask spread over an extended period to understand liquidity constraints.
- Investigate any news or press releases from the company, even if not formally filed with a regulatory body.
- Understand the specific regulatory environment in Japan for AS ONE Corporation's primary listing, if applicable.
- Evaluate the company's market capitalization and employee count as indicators of its operational scale and stability.
- Consider the long-term viability of its product lines and market position in its core sectors.
- Established operating history since 1933, indicating longevity and resilience in its market.
- Identified as a 'global supplier,' suggesting a broad operational footprint and established distribution networks.
- Specific and diverse product offerings across scientific, healthcare, and industrial sectors, indicating a real business with tangible products.
- A significant employee base of 711, reflecting a substantial operational scale and workforce.
- A market capitalization of $997.75M, suggesting a company of considerable size despite its OTC listing.
What Investors Ask About AS ONE Corporation (IUSDF) — Healthcare
What does AS ONE Corporation do?
AS ONE Corporation operates as a global supplier specializing in a comprehensive range of instruments and equipment for research, scientific applications, and the healthcare sector. Their extensive product catalog includes advanced biotechnology instruments like microscopes and tissue culture products, essential laboratory infrastructure such as fume hoods and storage solutions, and a wide array of consumables like beakers and hoses. Additionally, they cater to industrial clients with cleanroom tools and sterilization equipment, and to hospitals and nursing facilities with medical garments, care equipment, and sanitary products. Established in 1933 in Osaka, Japan, AS ONE serves critical demands across these specialized industries.
What are the key growth opportunities for IUSDF in healthcare?
AS ONE Corporation has significant growth opportunities within the healthcare sector, driven by an aging global population and continuous advancements in medical technology. The company can expand its market share by enhancing its offerings for hospital and nursing facility infrastructure, including advanced sterilizers, patient care equipment, and integrated nursing station solutions. Furthermore, as a supplier of medical garments, masks, and gloves, AS ONE is well-positioned to capitalize on ongoing demand for personal protective equipment and infection control products. Strategic partnerships and product innovation in specialized medical devices could further unlock growth in this critical and expanding market segment.
What are the main risks for IUSDF?
The primary risks for AS ONE Corporation (IUSDF) stem from its listing on the OTC Other market, which entails less stringent reporting requirements and an 'Unknown' disclosure status, leading to reduced transparency for investors. This can result in lower liquidity, wider bid-ask spreads, and increased price volatility compared to major exchange-listed stocks. Operationally, the company faces potential risks from intense competition within the medical distribution and scientific equipment sectors, economic downturns that could impact research and healthcare spending, and disruptions to its global supply chain. Furthermore, the absence of detailed financial disclosures makes it challenging for investors to fully assess the company's financial health and operational stability.
What are the key factors to evaluate for IUSDF?
AS ONE Corporation (IUSDF) holds an AI score of 46/100 (low). P/E: 16.9x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does IUSDF data refresh on this page?
IUSDF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven IUSDF's recent stock price performance?
AS ONE Corporation (IUSDF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse and extensive product catalog catering to multiple specialized industries (research, scientific, healthcare, industrial). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider IUSDF overvalued or undervalued right now?
AS ONE Corporation (IUSDF) trades at 16.9x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying IUSDF?
Before investing in AS ONE Corporation (IUSDF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Specific geographic reach beyond 'global supplier' is not detailed in the source data.
- Specific market sizes and timelines for growth opportunities were not provided in the source data and thus stated as 'Unknown'.
- Detailed CEO background and track record information beyond name and role were not provided in the source data and thus stated as 'Unknown'.
- No FMP PEER TICKERS were provided, so the 'competitors' array is empty.
- Analyst consensus or ratings were not provided in the source data, so the corresponding FAQ was omitted.